Madison-based Wyeth said it won U.S. approval of a low-dose form of Premarin to treat a condition that makes sexual intercourse painful for some women.
The estrogen cream was approved for the condition known as postmenopausal dyspareunia, the company said today in a statement distributed by PR Newswire. The disorder follows the atrophy, or thinning, of the vagina and vulva that can occur in menopause, usually between the ages of 45 to 55.
The cream has 0.5 grams of estrogens, the company said. The drug will be sold by prescription only. [APP]